Specialty code 390200000X · New Haven, CT
NPI
1972187854
Since 2021
Specialty
Specialty code 390200000X
Code 390200000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
20 York St
New Haven, CT, 06510
Phone (203) 688-4242
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.5M
135 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Mehr E Mathew prescribed most often to Medicare patients was Berinert (C1 Esterase Inhibitor), with 29 prescriptions and refills. In total Mehr E Mathew wrote 135 Medicare prescriptions that cost $1.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Berinert C1 Esterase Inhibitor | 29 | 29 | Under 11 | $1.4M |
| Azelastine Hcl Generic | 19 | 24 | 11 | $319 |
| Xolair Omalizumab | 12 | 16 | Under 11 | $49K |
Brand drugs: 54 claims; generic drugs: 81 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mehr E Mathew were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.